Fusion Antibodies (FAB LN)

Analysis

Health Care • United Kingdom

Fusion Antibodies is a Collaborative Research Organisation (CRO) specializing in antibody discovery, engineering, and supply. The company offers a range of services including antibody generation, development, production, characterization, and optimization for therapeutic drug and diagnostic applications. Fusion Antibodies is headquartered in Belfast, United Kingdom, and was established in 2001.

Refresh

Exchange Announcement • 15 Oct 2026 19:20

Result of AGM

Exchange Announcement • 15 Oct 2026 13:00

AGM statement H1 trading and research update

Exchange Announcement • 05 Oct 2026 13:00

Launch of new customer-focused website

Exchange Announcement • 22 Sep 2026 13:00

Posting of Annual Report & Notice of AGM

Exchange Announcement • 15 Sep 2026 21:42

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Result of AGM

AGM statement H1 trading and research update

Launch of new customer-focused website

Posting of Annual Report & Notice of AGM

REPLACEMENT: Final Results